Premium
Outcomes of children with rhabdomyosarcoma treated with intensive chemotherapy, surgery, and radiotherapy through a period of protocol revision at a South African center, 1990–2010
Author(s) -
Hendricks Marc,
Parkes Jeanette,
Pillay Komala,
Millar Alastair,
Eyssen Ann,
Numanoglu Alp,
Davidson Alan
Publication year - 2017
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.26248
Subject(s) - medicine , rhabdomyosarcoma , radiation therapy , stage (stratigraphy) , overall survival , cohort , chemotherapy , surgery , biopsy , pediatrics , sarcoma , pathology , paleontology , biology
A total of 75 children with biopsy‐proven rhabdomyosarcoma were treated at our institution between 1990 and 2010. Five‐year overall survival (OS) for the entire cohort was 58.7%. OS by stage was as follows: Stage 1 (80%), Stage 2 (80%), Stage 3 (54.1%), and Stage 4 (38.5%). There was a trend to suggest that revision of treatment approaches improved crude survival over time: pre‐2003 (OS 42.1%); 2003–2005 (OS 50.0%); 2005–2010 (OS 60.8%).